The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
Angelo Ruggiero,Fabrizio Martora,Gabriella Fabbrocini,Alessia Villani,Claudio Marasca,Matteo Megna,Luigi Fornaro,Rosita Comune,Luca Potestio
DOI: https://doi.org/10.2147/CCID.S377029
2022-12-20
Abstract:Angelo Ruggiero, 1 Fabrizio Martora, 1 Gabriella Fabbrocini, 1 Alessia Villani, 1 Claudio Marasca, 1 Matteo Megna, 1 Luigi Fornaro, 1 Rosita Comune, 2 Luca Potestio 1 1 Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; 2 Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy Correspondence: Angelo Ruggiero, Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini, 5, Naples, 80131, Italy, Tel +39 - 081 - 7462457, Fax +39 - 081 - 7462442, Email Teledermatology represented one of the most important and useful tools during the COVID-19 pandemic era. Indeed, due to the severe restriction, and to reduce the spread of the infection, different measures were applied among different countries and hospitals to ensure a continuity of care for patients. In this scenario, teledermatology played a central role, especially in the management of patients suffering from chronic inflammatory skin diseases. The aim of this narrative review is to describe the role of teledermatology during the COVID-19 pandemic to analyze main strengths and limitations of this tool, as well as to provide future perspectives in clinical applications. Keywords: teledermatology, telemedicine, COVID-19, psoriasis, atopic dermatitis, hidradenitis suppurativa The Coronavirus disease 2019 (COVID-19) outbreak represented a worldwide challenge, strongly impacting on overall health, lifestyle and global economy. 1 In order to reduce as much as possible the spread of the infection, several measures have been adopted among different countries to ensure a continuity of care for patients, deeply changing the daily clinical practice approach. 2,3 Among these, the transition from face-to-face visits to teleconsultations was one of the main strategy adopted to reduce the risk of infection, limiting the access to hospital only for severe diseases. 4 With regard to daily dermatological practice, teledermatology represented a useful tool to ensure a continuity of care for patients. 5 Furthermore, several new cutaneous manifestations have been linked to the COVID-19 infections, including COVID-19 related skin diseases, and a worsening of preexisting dermatological conditions, such as of the inflammatory skin diseases. 5 Moreover, dermatologists had to manage patients' hesitancy and doubts about the safety and effectiveness of conventional treatments and biologics in case of infection, the development or worsening of several dermatoses such as acne, rosacea, related to the use of personal protection equipment and the new lifestyle, and the management of inflammatory skin conditions [eg atopic dermatitis (AD), psoriasis, hidradenitis suppurativa (HS)] since their relapsing chronic clinical course strongly affecting patients' quality of life, and requiring a long term follow-up. 6–16 Telemedicine has been defined by the World Health Organization (WHO) as the Delivery of health care services, where distance is a critical factor, by all health care professionals using information and communication technologies for the exchange of valid information for diagnosis, treatment, and prevention of disease and injuries, research, and evaluation, and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities. 17 Even if the use of telemedicine has been proposed several years ago, the spreading of COVID-19 allowed a massive and rapid diffusion, and implementation of this service, becoming a valuable weapon during the pandemic era. 17,18 As note, two different types of telemedicine should be distinguished: synchronous (in which patient and clinicians are able to interact in real-time) and asynchronous (based on a store-and-forward system). 19 The aim of this narrative review is to describe the role of teledermatology during the COVID-19 pandemic in order to analyze main strengths and limitations of this tool, as well as to provide future perspectives in clinical applications. For the current review, literature research was performed on the PubMed, EBSCO, Embase, Google Scholar, Cochrane Skin, and MEDLINE databases (until October 20, 2022). Research was performed by using and matching the following terms: "COVID-19", "telemedicine", "teledermatology", "skin manifestations", "cutaneous disease", "acne", "psoriasis", "atopic dermatitis", "hidradenitis suppurativa", "urticaria", "alopecia", "rosacea", "eczema". Investigated manuscripts included metanalyses, reviews, letter to editor, real-life studies, case series and reports. The most relevant -Abstract Truncated-
dermatology